A systematic data review of the cost of rehydration therapy

Applied Health Economics and Health Policy

Volumn 8, Issue 3, 2010, Pages 203-214

  Pershad, Jay ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GASTROENTERITIS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; COST OF ILLNESS; DEHYDRATION; DISEASE SEVERITY; DRUG ADMINISTRATION ROUTE; HOSPITAL COST; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTRAVENOUS REHYDRATION THERAPY; MEDICAL INSTRUMENTATION; META ANALYSIS; ORAL REHYDRATION THERAPY; OUTPATIENT CARE; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; REHYDRATION; REVIEW; SUBCUTANEOUS REHYDRATION THERAPY; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT PLANNING; TREATMENT RESPONSE; VEIN CATHETERIZATION;

DEHYDRATION; FLUID THERAPY; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; HYPODERMOCLYSIS; INFUSIONS, INTRAVENOUS;

EID: 77951639504     PISSN: 11755652     EISSN: 11791896     Source Type: Journal    
DOI: 10.2165/11534500-000000000-00000     Document Type: Review

References (63)

1. Xiao H, Barber J, Campbell ES. Economic burden of de-hydration among hospitalized elderly patients. Am J Health Syst Pharm 2004 Dec 1; 61 (23): 2534-2540
2. Zimmerman CM, Bresee JS, Parashar UD, et al. Cost of diarrhea-associated hospitalizations and outpatient visits in an insured population of young children in the United States. Pediatr Infect Dis J 2001 Jan; 20 (1): 14-19
3. Malek MA, Curns AT, Holman RC, et al. Diarrhea-and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics 2006 Jun; 117 (6): 1887-1892
4. Fischer TK, Viboud C, Parashar U, et al. Hospitalizations and deaths from diarrhea and rotavirus among children 5 years of age in the United States, 1993-2003. J Infect Dis 2007 Apr 15; 195 (8): 1117-1125
5. Pierce NF, Hirschhorn N. Oral fluid: a simple weapon against dehydration in diarrhoea. WHO Chron 1977 Mar; 31 (3): 87-93
6. Santosham M, Keenan EM, Tulloch J, et al. Oral rehydra-tion therapy for diarrhea: an example of reverse transfer of technology. Pediatrics 1997 Nov; 100 (5): E10
7. World Health Organization. The treatment of diarrhoea: a manual for physicians and other senior health workers [report no. 4]. Geneva: WHO, 2005
8. King CK, Glass R, Bresee JS, et al. Managing acute gas-troenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep 2003 Nov 21; 52 (RR-16): 1-16
9. American Academy of Pediatrics Provisional Committee on Quality Improvement, Subcommittee on Acute Gastroenteritis. Practice parameter: the management of acute gastroenteritis in young children. Pediatrics 1996 Mar 97 3 424-435
10. Cohen MB, Mezoff AG, Laney Jr DW, et al. Use of a single solution for oral rehydration and maintenance therapy of infants with diarrhea and mild to moderate dehydration. Pediatrics 1995 May; 95 (5): 639-645
11. Santosham M, Daum RS, Dillman L, et al. Oral rehydration therapy of infantile diarrhea: a controlled study of well-nourished children hospitalized in the United States and Panama. N Engl J Med 1982 May 6; 306 (18): 1070-1076
12. Santosham M, Burns B, Nadkarni V, et al. Oral rehydration therapy for acute diarrhea in ambulatory children in the United States: a double-blind comparison of four different solutions. Pediatrics 1985 Aug; 76 (2): 159-166
13. Listernick R, Zieserl E, Davis AT. Outpatient oral rehy-dration in the United States. Am J Dis Child 1986 Mar; 140 (3): 211-215
14. Tamer AM, Friedman LB, Maxwell SR, et al. Oral rehy-dration of infants in a large urban US medical center. J Pediatr 1985 Jul; 107 (1): 14-19
15. Mackenzie A, Barnes G. Randomised controlled trial com-paring oral and intravenous rehydration therapy in children with diarrhoea. BMJ 1991 Aug 17; 303 (6799): 393-396
16. Bellemare S, Hartling L, Wiebe N, et al. Oral rehydration versus intravenous therapy for treating dehydration due to gastroenteritis in children: a meta-analysis of randomised controlled trials. BMC Med 2004 Apr 15; 2: 11
17. Ozuah PO, Avner JR, Stein RE. Oral rehydration, emer-gency physicians, and practice parameters: a national survey. Pediatrics 2002 Feb; 109 (2): 259-261
18. Conners GP, Barker WH, Mushlin AI, et al. Oral versus intravenous: rehydration preferences of pediatric emergency medicine fellowship directors. Pediatr Emerg Care 2000 Oct; 16 (5): 335-338
19. Reis EC, Goepp JG, Katz S, et al. Barriers to use of oral rehydration therapy. Pediatrics 1994 May; 93 (5): 708-711
20. Snyder JD. Use and misuse of oral therapy for diarrhea: comparison of US practices with American Academy of Pediatrics recommendations. Pediatrics 1991 Jan; 87 (1): 28-33
21. Stanley A, O'Keeffe ST, Faull C, et al. Hypodermoclysis guidelines on the technique. Wrexham: CP Pharmaceuticals Ltd, 1998
22. Hechter O, Dopkeen SK, Yudell MH. The clinical use of hyaluronidase in hypodermoclysis. J Pediatr 1947; 30 (6): 645-656
23. Burket LC, Gyorgy P. Clinical observations on the use of hyaluronidase. Ann N-Y Acad Sci 1950; 52 (7): 1171-1179
24. Jaworski A, Farley Jr JE. Hyaluronidase in administration of fluids. Am J Dis Child 1950; 79 (1): 59-64
25. Schwartzman J. Hyaluronidase: a review of its therapeutic use in pediatrics. J Pediatr 1951; 39 (4): 491-502
26. Boyd HW. Hyaluronidase as an aid to administration of fluid in the treatment of dehydration in infants. Glasgow Med J 1951 Jul; 32 (7): 214-217
27. Goodfellow AM, Pocock R, McCreary JF. Treatment of dehydration in infancy using continuous interstitials and hyaluronidase. Can Med Assoc J 1952 Jan; 66 (1): 8-11
28. Barua P, Bhowmick BK. Hypodermoclysis: a victim of his-torical prejudice. Age Ageing 2005 May; 34 (3): 215-217
29. Hall BD. Complications of hypodermoclysis (re-emphasis with a case presentation). J Ky Med Assoc 1968 Jul; 66 (7): 626-627
30. Abbott WE, Levey S, Foreman RC, et al. The danger of administering parenteral fluids by hypodermoclysis. Surgery 1952 Aug; 32 (2): 305-315
31. Farrand S, Campbell AJ. Safe, simple subcutaneous fluid administration. Br J Hosp Med 1996 Jun 5; 55 (11): 690-692
32. Berger EY. Nutrition by hypodermoclysis. J Am Geriatr Soc 1984 Mar; 32 (3): 199-203
33. Challiner YC, Jarrett D, Hayward MJ, et al. A comparison of intravenous and subcutaneous hydration in elderly acute stroke patients. Postgrad Med J 1994 Mar; 70 (821): 195-197
34. Fainsinger RL, MacEachern T, Miller MJ, et al. The use of hypodermoclysis for rehydration in terminally ill cancer patients. J Pain Symptom Manage 1994 Jul; 9 (5): 298-302
35. O'Keeffe ST, Lavan JN. Subcutaneous fluids in elderly hospital patients with cognitive impairment. Gerontology 1996; 42 (1): 36-39
36. Frisoli Jr A, de Paula AP, Feldman D, et al. Subcutaneous hydration by hypodermoclysis: a practical and low cost treatment for elderly patients. Drugs Aging 2000 Apr; 16 (4): 313-319
37. Pirrello RD, Ting Chen C, Thomas SH. Initial experiences with subcutaneous recombinant human hyaluronidase. J Palliat Med 2007 Aug; 10 (4): 861-864
38. Yap LK, Tan SH, Koo WH. Hypodermoclysis or sub-cutaneous infusion revisited. Singapore Med J 2001 Nov; 42 (11): 526-529
39. Slesak G, Schnurle JW, Kinzel E, et al. Comparison of subcutaneous and intravenous rehydration in geriatric patients: a randomized trial. J Am Geriatr Soc 2003 Feb; 51 (2): 155-160
40. Allen CH, Etzwiler LS, Miller MK, et al. Recombinant hu-man hyaluronidase-enabled subcutaneous pediatric rehy-dration. Pediatrics 2009 Oct 5; 124 (5): e859-68
41. Hahn B, Mace SE, Maher G, et al. Hydration therapy in infants and children: recombinant human hyaluronidase-facilitated subcutaneous versus intravenous [poster]. Scientific Assembly of the American College of Emergency Physicians; 2009 Oct 5-8; Boston (MA)
42. Bookbinder LH, Hofer A, Haller MF, et al. A recombi-nant human enzyme for enhanced interstitial transport of therapeutics. J Control Release 2006 Aug 28; 114 (2): 230-241
43. Frost GI. Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration. Expert Opin Drug Deliv 2007 Jul; 4 (4): 427-440
44. Yocum RC, Kennard D, Heiner LS. Assessment and impli-cation of the allergic sensitivity to a single dose of recombi-nant human hyaluronidase injection: a double-blind, placebo-controlled clinical trial. J Infus Nurs 2007 Sep; 30 (5): 293-299
45. Thomas JR, Yocum RC, Haller MF, et al. Assessing the role of human recombinant hyaluronidase in gravity-driven subcutaneous hydration: the INFUSE-LR study. J Palliat Med 2007; 10 (6): 1312-1320
46. Kokotis K. Cost containment and infusion services. J Infus Nurs 2005 May; 28 (3 Suppl.): S22-32
47. van Zanten AR, Engelfriet PM, van Dillen K, et al. Impor-tance of nondrug costs of intravenous antibiotic therapy. Crit Care 2003 Dec; 7 (6): R184-90
48. Hussain NA, Warshaw G. Utility of clysis for hydration in nursing home residents. J Am Geriatr Soc 1996 Aug; 44 (8): 969-973
49. Avery ME, Snyder JD. Oral therapy for acute diarrhea: the underused simple solution. N Engl J Med 1990 Sep 27; 323 (13): 891-894
50. Burkhart DM. Management of acute gastroenteritis in children. Am Fam Physician 1999 Dec; 60 (9): 2555-2556
51. Santolucito JB. A retrospective evaluation of the timeliness of physician initiated PICC referrals. JVAD 2001; 6 (3): 20-26
52. Worobec G, Brown MK. Hypodermoclysis therapy: in a chronic care hospital setting. J Gerontol Nurs 1997 Jun; 23 (6): 23-28
53. Atherly-John YC, Cunningham SJ, Crain EF. A rando-mized trial of oral versus intravenous rehydration in a pe-diatric emergency department. Arch Pediatr Adolesc Med 2002 Dec; 156 (12): 1240-1243
54. Fonseca BK, Holdgate A, Craig JC. Enteral versus intra-venous rehydration therapy for children with gastroenteritis: a meta-analysis of randomized controlled trials. Arch Pediatr Adolesc Med 2004 May; 158 (5): 483-490 (Pubitemid 38623587)
55. Spandorfer PR, Alessandrini EA, Joffe MD, et al. Oral versus intravenous rehydration of moderately dehydrated children: a randomized, controlled trial. Pediatrics 2005 Feb; 115 (2): 295-301
56. Bruera E, Pruvost M, Schoeller T, et al. Proctoclysis for hydration of terminally ill cancer patients. J Pain Symptom Manage 1998 Apr; 15 (4): 216-219
57. Remington R, Hultman T. Hypodermoclysis to treat dehy-dration: a review of the evidence. J Am Geriatr Soc 2007 Dec; 55 (12): 2051-5 Redbook. Montvale (NJ): Medical Economics Data, 1999
58. Knauss MD, Walton T, Macon EJ. Switching from i.v. to s.c. epoetin in hemodialysis patients. Am J Health Syst Pharm 2002 Sep 15; 59 (18): 1783-1784
59. McFarlane PA, Hillmer MP, Dacouris N. A change from subcutaneous to intravenous erythropoietin increases the cost of anemia therapy. Nephron Clin Pract 2007; 107 (3): c90-6
60. Lee DH, Linker RA, Paulus W, et al. Subcutaneous immu-noglobulin infusion: a new therapeutic option in chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2008 Oct 5; 37 (3): 406-409
61. Della MT, Steinmetz L, Campos PR, et al. Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care 2005 Aug; 28 (8): 1856-1861
62. Fudin J, Smith HS, Toledo-Binette CS, et al. Use of contin-uous ambulatory infusions of concentrated subcutaneous (s.q.) hydromorphone versus intravenous (i.v.) morphine: cost implications for palliative care. Am J Hosp Palliat Care 2000 Sep; 17 (5): 347-353
63. Freedman SB, Adler M, Seshadri R, et al. Oral ondansetron for gastroenteritis in a pediatric emergency department. N Engl J Med 2006 Apr 20; 354 (16): 1698-1705